Jianpi Yishen prescription

Jianpi Yishen prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by Longhua Hospital, Shanghai University of Traditional Chinese Medicine, for the treatment of diabetic kidney disease (DKD). The formula is specifically indicated for patients exhibiting the 'spleen and kidney qi deficiency' syndrome, a common TCM diagnosis in chronic renal conditions. Its therapeutic goals are to tonify the spleen, benefit the kidney, and improve renal function, thereby reducing proteinuria and slowing the progression of stage IV DKD. In clinical research, the prescription is often evaluated alongside modern diabetes classification systems, such as the ANDIS (All New Diabetics in Scania) classification, to refine patient selection and optimize treatment outcomes through a combination of traditional syndrome differentiation and precision medicine approaches.